These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1477249)

  • 1. General guidelines for clinical bacteriology. Infectious Diseases Society of America and the Food and Drug Administration.
    Thrupp LD; Cleeland R; Jones RN; Novick WJ; Reller LB; Thornsberry CL; Washington JA
    Clin Infect Dis; 1992 Nov; 15 Suppl 1():S339-46. PubMed ID: 1477249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality microbiological diagnostics and antimicrobial susceptibility testing, an essential component of antimicrobial resistance surveillance and control efforts in Pacific island nations.
    Ferguson JK; Joseph J; Kangapu S; Zoleveke H; Townell N; Duke T; Manning L; Lavu E
    Western Pac Surveill Response J; 2020; 11(1):41-46. PubMed ID: 32963890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M
    J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for rapid transmission of microbiology reports.
    Ryan KJ
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6 Suppl):33S-38S. PubMed ID: 3905231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between bacteriology reports and clinical assessments.
    Gedebou M; Akalu T
    Ethiop Med J; 1977 Jan; 15(1):15-27. PubMed ID: 326548
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating antibiograms to monitor drug resistance.
    El-Azizi M; Mushtaq A; Drake C; Lawhorn J; Barenfanger J; Verhulst S; Khardori N
    Emerg Infect Dis; 2005 Aug; 11(8):1301-2. PubMed ID: 16102325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.
    Washington JA
    Clin Microbiol Rev; 1991 Apr; 4(2):150-5. PubMed ID: 2070343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ground rules of microbiological laboratory diagnosis by antibacterial drug therapy].
    Ortel S
    Z Arztl Fortbild (Jena); 1977 Apr; 71(7):337-42. PubMed ID: 325928
    [No Abstract]   [Full Text] [Related]  

  • 10. Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens.
    Kirby JE; Brennan-Krohn T; Smith KP
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of new anti-infective drugs for the treatment of infectious arthritis in adults. Infectious Diseases Society of America and the Food and Drug Administration.
    Norden C; Nelson JD; Mader JT; Calandra GB
    Clin Infect Dis; 1992 Nov; 15 Suppl 1():S167-71. PubMed ID: 1477225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NCCLS in antimicrobial susceptibility testing and monitoring.
    Ginocchio CC
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S7-11. PubMed ID: 11977864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical microbiology as a basis of antimicrobial chemotherapy].
    Spencker FB
    Z Gesamte Inn Med; 1992 Sep; 47(9):394-7. PubMed ID: 1441666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The microbiology laboratory in the strategy of antibiotic therapy].
    Cavallo G
    G Batteriol Virol Immunol; 1985; 78(1-6):107-24. PubMed ID: 3915737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children. Infectious Diseases Society of America and the Food and Drug Administration.
    Nelson JD; Norden C; Mader JT; Calandra GB
    Clin Infect Dis; 1992 Nov; 15 Suppl 1():S172-6. PubMed ID: 1477226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Susceptibility Testing: Genotypic and Phenotypic Methods.
    Humphries RM
    Clin Lab Med; 2020 Dec; 40(4):433-446. PubMed ID: 33121613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical bacteriology in low-resource settings: today's solutions.
    Ombelet S; Ronat JB; Walsh T; Yansouni CP; Cox J; Vlieghe E; Martiny D; Semret M; Vandenberg O; Jacobs J;
    Lancet Infect Dis; 2018 Aug; 18(8):e248-e258. PubMed ID: 29519767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial selection, administration and dosage.
    Baggot JD
    J S Afr Vet Assoc; 1998 Dec; 69(4):174-85. PubMed ID: 10192094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.
    Tenover FC; Mohammed MJ; Stelling J; O'Brien T; Williams R
    J Clin Microbiol; 2001 Jan; 39(1):241-50. PubMed ID: 11136778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Vázquez M; Marín M; Nicola F; Radice M; Galas M; Pasterán F; Bantar C; Casellas JM; Kovensky Pupko J; Couto E; Goldberg M; Lopardo H; Gutkind G; Soloaga R;
    Rev Argent Microbiol; 2005; 37(1):57-66. PubMed ID: 15991480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.